Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 table…
- Recall date
- March 7, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0291-2025
- FDA classification
- Class II
- Brand / firm
- Mylan Institutional, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Super-Potent Drug: Out of specification potency results were obtained.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
Get recall alerts
Free email alert whenever Mylan Institutional, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Institutional, Inc.